Being highly metabolically active, VAT can continuously release adipokines such as resistin, leptin, adiponectin, and visfatin into the portal circulation [18], which may involve in the development and progression of AP by modulating oxidative stress and inflammatory responses and influencing the severity of AP. The gene discussed is LEP; the disease is alkaline phosphatase measurement.